This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sareum Limited. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Jamie Conor Marshall: Innovator in Tyk2 Inhibition
Introduction
Jamie Conor Marshall is a notable inventor based in Northumberland, GB. She has made significant contributions to the field of pharmaceutical innovations, particularly in the development of inhibitors. Her work is recognized for its potential impact on therapeutic applications.
Latest Patents
Jamie holds a patent for "Crystalline Forms of a Tyk2 Inhibitor." This invention represents a crucial advancement in the search for effective treatments targeting specific pathways in disease processes. The patent showcases her expertise and commitment to innovation in the pharmaceutical industry.
Career Highlights
Jamie Conor Marshall is currently employed at Sareum Limited, a company known for its focus on drug discovery and development. Her role at Sareum has allowed her to contribute to groundbreaking research and development efforts in the field of medicinal chemistry.
Collaborations
Throughout her career, Jamie has collaborated with esteemed colleagues, including John Mykytiuk and John Charles Reader. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to successful outcomes in their projects.
Conclusion
Jamie Conor Marshall is a pioneering inventor whose work in Tyk2 inhibition exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions continue to pave the way for advancements in therapeutic solutions.